Recently, we were highly intrigued by the study published
in this journal by Xu et al. (1), which examines the
maintenance immunotherapy following microwave ablation
(MWA) combined with drug-eluting bead bronchial arterial
chemoembolization (DEB-BACE) in patients with advanced
non-small cell lung cancer (NSCLC). We are extremely
grateful for the valuable insights offered by the authors.
Although this study offers significant reference points for
future clinical practice, it is important to acknowledge
several limitations that, if resolved, could strengthen the
reliability and validity of the findings.
基金：
National Key Research and Development Program of China [2023YFC2507104]
第一作者机构：[1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Med Sch, Dept Pulm & Crit Care Med, Kunming 650500, Peoples R China
共同第一作者：
通讯作者：
通讯机构：[1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Med Sch, Dept Pulm & Crit Care Med, Kunming 650500, Peoples R China[4]Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Pulm & Crit Care Med, Guangzhou 510080, Peoples R China
推荐引用方式(GB/T 7714)：
Deng Yi,Li Yongyu,Xu Rongde,et al.The critical role of PD-L1 expression in immunotherapy for advanced non-small cell lung cancer[J].QUANTITATIVE IMAGING IN MEDICINE AND SURGERY.2025,15(5):doi:10.21037/qims-2025-209.
APA：
Deng, Yi,Li, Yongyu,Xu, Rongde,Li, Jing&Cui, Wei.(2025).The critical role of PD-L1 expression in immunotherapy for advanced non-small cell lung cancer.QUANTITATIVE IMAGING IN MEDICINE AND SURGERY,15,(5)
MLA：
Deng, Yi,et al."The critical role of PD-L1 expression in immunotherapy for advanced non-small cell lung cancer".QUANTITATIVE IMAGING IN MEDICINE AND SURGERY 15..5(2025)
